You are on page 1of 6

QC/QA 6.

Product Quality Review (PQR)


OUTLINE  regular periodic quality reviews of
I. Basic Principles all registered drug products to verify
II. Raw Material Quality Control consistency of the existing process
(RMQC) and to identify product and process
III. Packaging Material Quality Control improvements.
(PMQC). 7. Quality Risk Management (QRM)
I. BASIC PRINCIPLES  a systematic process for the
A. DEFINITION OF TERMS assessment, control,
1. Quality communication, and review of risks
 totality features or conformance to to the qualitv of the product
specifications of a product B. QUALITY UNIT
 Ensures that products:  An organizational unit independent
of Production which fulfills both
 Are fit for their intended use Quality Assurance and Quality
 Safe Control responsibilities.
 Compliant with the CA UNIT
requirements of the  ensures that quality policies
marketing authorization  are followed
2. Total Quality Management (TQM)  audit and monitoring
 A combined team effort to develop,  primary contact with
produce, market, distribute, and regulatory agencies
control products that are safe and  prepares SOPs
will be effective for the time they QC UNIT
remain in the marketplace  conducts sampling and
3. Quality Assurance (QA) testing of RM & FP
 totality of the organized  inspects PM components
arrangements made with the  performs environmental
objective of ensuring that products  monitoring
are of the quality required for their C. DOCUMENTS
intended use 1. Monograph
4. Current Good Manufacturing Practice  specifies all the tests to be
(cGMP) conducted on a material and the
 part of QA which ensures that expected results
products are consistently produced 2. SOP
and controlled to the quality  step-by-step instruction for doing a
standards appropriate to their particular task or activity
intended use 3. COA
5. Quality Control (QC)  shows the actual results of all tests
 part of cGMP concerned with conducted on a material to show
sampling, specifications, testing, compliance with standards
organization, documentation, and 4. MSDS
release procedures
 contains information on the  Classification:
potential health effects of exposure 1. According to Magnitude
to chemicals and on safe working a. Critical Defect - may endanger
procedures when handling chemical life of patient
products b. Major Defect - does not
D. SAMPLING endanger life of patient but
 the process of removal of an affects the function of the
appropriate number of items (n) product
from a population (N) C. Minor Defect - does not
 Sampling Plans: endanger life of patient & does
1. MIL-STD-105E - most common not affect the function of the
(old) product
2. ANSI/ASQZ1.4-2008 - most 2. According to Measurability
common (new) a. Variable Defect - measured by
3. Square Root System - easier (use an instrument
in exam) b. Attributive Defect – measured
E. CONTROL CHARTS by inspection
 graphs on which the quality of the 3. According to Nature
product is plotted as manufacturing a. Ocular Defect - can be seen by
is actually proceeding the naked eye
 Types: b. Internal Defect - cannot be
1. p-Chart - proportion of defectives seen by the nakedeye
2. np-Chart-non-proportion H. PRODUCT RECALL
(number) of defectives  removal of product from the market
3. X Bar Chart - used for measurable because it is either defective or
characteristics potentially harmful
 Warning Limit – alerts the  Classification of Product Recall:
operator to closely monitor the 1. Class I Recall - may cause death
process or serious adverse health
 Action Limit – alerts the operator consequences
to stop the process and do 2. Class I Recall - may cause
corrective action temporary/medically reversible
F. VALIDATION & QUALIFICATION adverse health consequences
1. Validation - the action of proving 3. Class III Recall - not likely to
and documenting that any process, cause adverse health
procedure or method actually leads consequences
to the expected results. I. STABILITY STUDIES
2. Qualification - the action of 1. Stability
proving that premises, systems or  capacity of a drug to remain within
equipment work correctly and specification
actually lead to expected results.  Minimum Acceptable
G. PRODUCT DEFECTS  Potency: 90%
 non-conformance to a standard  Drug products are mainly
or requirement decomposed by:
a. Hydrolysis using exaggerated storage
o Prevented by reduction or conditions
elimination of water from o Testing Period: 0, 3, 6
the preparation c. Stress Testing
b. Oxidation  elucidates the intrinsic
o Prevented by antioxidants stability of the drug
(ex: Vit C & E) substance and identify the
c. Photolysis likely degradation products
o Prevented by using light-  carried out under more
resistant containers severe conditions
2. Shelf-life (tgo) II.Raw Material Quality Control (RMQC)
 period of time during which a A. HANDLING OF RM
product is expected to remain within o Quarantine - status of materials
specification which are isolated physically while a
 estimated using the Arrhenius decision is awaited on their release,
equation rejection, or reprocessing
3. Expiration Date o All quarantined materials are
 time or date prior to which a labeled with
product is expected to remain stable o YELLOW color
and after which it must not be used o Materials that conform to
 calculated using this formula: tests are labeled with GREEN
o Expiration Date = color
Manufacturing Date + Shelf- o Materials that failed or are
life rejected are labeled with
4. Stability Studies RED color
 used to estimate the shelf-life of a o Warehouse Distribution Practices:
drug product 1. First in-First out (FIFO)
 evaluated over time in the same o In this technique, the rule is
container closure to move first the stocked
 system in which the drug product is products or the products
marketed that are brought in first
 based on ASEAN Guidelines on 2. First expiry-First out (FEFO)
Stability Studies o In this technique, the
 Climatic Zones products whose expiration
dates are approaching are
moved out of the warehouse
first
B. IDENTIFICATION TEST
o to confirm the identity of a chemical
 Types of Stability Studies substance
b. Accelerated Studies o Methods:
o designed to increase the rate 1. Chemical Methods
of chemical degradation by o Color reactions
o Precipitation
o Evolution of gas
2. Instrumental Methods
o Spectroscopy
o Chromatography
C. ASSAY
o to determine the amount of API or
biologic activity
o Methods:
1. Chemical Assay
o Titrimetry
o Instrumental methods D. LIMIT TEST
2. Biologic Assay o to measure small amounts of
o Animal assay impurities in a RM
o Microbial assay o Types of Impurities:
a. Animal Assay 1. Gross Impurities - dirt or insoluble
matter
2. Biological Impurities -
microorganism
3. Chemical Impurities - by-products,
degradation products, reagents,
catalysts, ligands, heavy metals, or
b. Microbial Assay residual solvents
o Methods: o Examples:
1. Cylinder Plate Method
o uses a cylinder or paper
disc impregnated with
the sample, placed on a
solidified nutrient
medium in a Petri dish
o based on the diameter of E. PHYSICAL TESTS
o can be used for identification and
the zone of inhibition
2. Turbidimetric Method determination of concentration of a
o uses a test tube filled with component
o may also be used to determine the
fluid nutrient medium,
where the test organism is presence of impurities
inoculated 1. Specific Gravity
o based on measurement of o the ratio of the density of a
transmittance substance to that of a
reference substance at 25 °C
o measured using a
pycnometer or Mohr
Westphal balance
o Alcohol: measured using a  Method IB: Residual
hydrometer at 15.56 °C  Method IC:
2. Refractive Index (n) Coulometric
o ratio of the velocity of light in air to
the velocity of light in the substance
at 25°C
o represented by the formula:

o where i= angle of incident ray

o measured using an Abbe


refractometer

3. Optical Rotation (a)


o measure of its ability to rotate an
incident plane of polarized light
o may be dextrorotatory or o Method I: Azeotropic Distillation
levorotatory  based on distillation of
o measured using a polarimeter water with toluene/
xylene
4. Solubility
 uses a toluene-moisture
apparatus
o Method Ill: Gravimetry
 based on loss on drying
at 110-120 °C for
inorganic materials and
105 °C for organic
materials
5. BP-MP III.Packaging Material Quality Control
o indicates presence of impurities (PMQC).
6. Loss on Drying A. TESTS FOR GLASS
o determines the amount of volatile 1. Hydrolytic Resistance (Leaching)
matter driven off after drying o Old SP Tests
7. Water Determination
o Method I: Karl-Fischer Titrimetry
o based on the rxn of water
and KFR
o KFR Components:
 Sulfur dioxide a. Powdered Glass Test
 lodine o Sample: crushed Type I and
 Pyridine Type III glass
 Anhydrous Methanol o Method: Acid-base titration
o Types: with 0.02 N H,SO VS using
 Method IA: Direct
methyl red as indicator

b. Water Attack Test


o Sample: inner surface of
Type Il glass
o Method: Acid-base
titration with 0.02 N
H,SO, VS using methyl
red as indicator
c.Surface Glass Test
o Sample: inner surface of
Type I and Ill glass
o Method: Acid-base
titration with 0.1 N HCI
VS using methyl red as
indicator
 New USP Tests

2. Light Transmission
 for colored glass containers
 Limit: NMT 10% at any wavelength
in the range of 290 to 450 nm
3. Arsenic
 for Type I or Type Il glass container
 Method: same w/ limit test for As
 Limit: NMT 0.1 ug per g

B. TESTS FOR PLASTIC


1. Biological Reactivity Tests In Vivo

2. Biological Reactivity Tests In Vitro

You might also like